PPARdelta agonist-mediated ROS stimulates mouse embryonic stem cell proliferation through cooperation of p38 MAPK and Wnt/beta-catenin
Related Experiment Video
Updated: Jun 25, 2026

Modified Mouse Embryonic Stem Cell based Assay for Quantifying Cardiogenic Induction Efficiency
Published on: April 22, 2011
A Young Jeong1, Min Young Lee, Sang Hun Lee
1Department of Veterinary Physiology, Biotherapy Human Resources Center (BK 21), College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.
Abstract:
PPARdelta (peroxisome proliferator-activated receptor delta) is a member of the nuclear receptor superfamily. However, its function in tissues and cells is unknown, particularly as related to stem cell biology. We therefore investigated the PPARdelta effects on DNA synthesis in mouse embryonic stem cells (ES cells) and its related signal pathways. PPARdelta increased biphasic reactive oxygen species (ROS) production at 15 min and at 120 min incubation. PPARdelta significantly increased [(3)H] thymidine incorporation levels at various concentrations (10(-8) M to 10(-6) M) and incubation times (12 to 48 hr), and this activity was blocked by antioxidants. In addition, PPARdelta increased protein kinase C (PKC), cytosolic phospholipase A(2) (cPLA(2)) and p38 mitogen-activated protein kinase (p38 MAPK) phosphorylation, and Wnt/beta-catenin activation. PPARdelta increased the protein levels of cell cycle regulators, and these levels were abolished by antioxidants, bisindolymaleimide I, SB203580 and beta-catenin specific siRNA. In addition, the effect of PPARdelta on increased [(3)H] thymidine incorporation was blocked by bisindolymaleimide I, SB203580 and beta-catenin specific siRNA. In conclusion, PPARdelta agonist enhanced mouse ES cells proliferation through ROS-mediated p38 MAPK and Wnt/beta-catenin activation.
Insights
Peroxisome proliferator-activated receptor delta (PPARdelta) enhances mouse embryonic stem cell proliferation. This occurs via reactive oxygen species (ROS) production, activating p38 MAPK and Wnt/beta-catenin pathways, promoting DNA synthesis.
Area of Science:
- Stem cell biology
- Molecular signaling pathways
- Nuclear receptor superfamily
Background:
- The function of PPARdelta in cellular processes, especially stem cell biology, remains largely uncharacterized.
- Investigating PPARdelta's role is crucial for understanding its impact on stem cell behavior.
Purpose of the Study:
- To elucidate the effects of PPARdelta on DNA synthesis in mouse embryonic stem cells (ES cells).
- To identify the specific signaling pathways modulated by PPARdelta in ES cells.
Main Methods:
- Treatment of mouse ES cells with a PPARdelta agonist.
- Measurement of reactive oxygen species (ROS) production.
- Assessment of [(3)H] thymidine incorporation to quantify DNA synthesis.
- Analysis of protein phosphorylation (PKC, cPLA(2), p38 MAPK) and Wnt/beta-catenin activation.
- Evaluation of cell cycle regulator protein levels.
- Inhibition studies using antioxidants, specific kinase inhibitors (bisindolymaleimide I, SB203580), and siRNA for beta-catenin.
Main Results:
- PPARdelta agonist induced biphasic ROS production.
- Significant increase in [(3)H] thymidine incorporation, indicating enhanced DNA synthesis, which was blocked by antioxidants.
- PPARdelta activation led to increased phosphorylation of p38 MAPK and activation of Wnt/beta-catenin signaling.
- Elevated protein levels of cell cycle regulators were observed, dependent on ROS, p38 MAPK, and Wnt/beta-catenin pathways.
- Inhibition of these pathways abolished the proliferative effect of PPARdelta.
Conclusions:
- PPARdelta agonist promotes proliferation of mouse ES cells.
- The proliferative effect is mediated by ROS generation, leading to the activation of p38 MAPK and Wnt/beta-catenin signaling pathways.
- These findings reveal a novel mechanism by which PPARdelta influences stem cell proliferation.
More Related Videos
15:13Structure-function Studies in Mouse Embryonic Stem Cells Using Recombinase-mediated Cassette Exchange
Published on: April 27, 2017
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017